Help appealing denials for this phosphate absorption inhibitor.

Appeal Your Xphozah Denial

Don't let your insurer deny access to this treatment for high phosphorus levels.

Understanding Your Xphozah (tenapanor) Denial

Xphozah (tenapanor) is an FDA-approved medication for controlling serum phosphorus in adults with chronic kidney disease on dialysis. Unlike traditional phosphate binders, Xphozah works by blocking phosphate absorption in the gut. This offers an important option for patients who cannot adequately control phosphorus with binders alone or who experience side effects from binders.

Common Reasons for Denial

! Must try phosphate binders first
! Not on formulary
! Prior authorization required
! Dose limits or quantity restrictions
! Medicare Part D coverage changes
! Cost-effectiveness criteria
! Inadequate documentation of binder failure

How We Help

We help you document your phosphorus levels, why traditional phosphate binders have failed or are inadequate, and how Xphozah's unique mechanism of action addresses your needs.

Start your Xphozah appeal — it takes about 3 minutes.

Some Types of Evidence We Can Use For Supporting Your Appeal

✓ Tenapanor significantly reduces serum phosphorus levels in dialysis patients.

✓ Xphozah offers a novel mechanism distinct from phosphate binders for controlling hyperphosphatemia.

✓ Combination therapy with tenapanor and binders provides additional phosphorus reduction.

✓ Managing hyperphosphatemia reduces cardiovascular risk in chronic kidney disease patients.

Patient Assistance & Copay Programs

These programs may help reduce your costs while you appeal:

ArdelyxAssist Patient Support

ArdelyxAssist provides insurance navigation, copay assistance, and patient assistance for eligible patients. Call 877-527-3927.

Eligibility requirements and program terms may change. Please verify current details directly with each organization.

Patient Advocacy & Support Organizations

These organizations provide education, support, and advocacy for patients:

American Kidney Fund

Leading kidney nonprofit fighting kidney disease through patient services and advocacy.

National Kidney Foundation

75 years of impact in kidney health through advocacy, research, and education.

Frequently Asked Questions

Document specific side effects like GI upset, pill burden, or drug interactions. Xphozah offers an alternative mechanism that may be better tolerated.

Coverage policies have evolved. The ArdelyxAssist program can help navigate current coverage options and provide financial assistance for eligible patients.

Ready to Fight Your Xphozah (tenapanor) Denial?

Our free AI-powered tool will help you generate a compelling appeal letter in minutes.

Start Your Appeal Chat with AI Assistant

Disclaimer: Fight Health Insurance is not affiliated with, endorsed by, or partnered with any pharmaceutical manufacturer, healthcare provider, medical device company, or patient assistance program, including Ardelyx. All information provided is for educational and informational purposes only and does not constitute medical or legal advice. Please consult with your healthcare provider regarding treatment options and with your insurance company regarding coverage decisions.